Regeneron Pharmaceuticals (REGN) Shares Outstanding (2009 - 2026)

Regeneron Pharmaceuticals' Shares Outstanding (Entity) history runs 18 years deep, the most recent figure standing at $102.8 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) fell 2.19% year-over-year to $102.8 million; the TTM figure through Jun 2026 stood at $102.8 million (down 2.19% YoY), while the FY2025 annual figure was $104.6 million, down 3.06% from the prior year.
• Shares Outstanding (Entity) for Q2 2026 stood at $102.8 million, down from $104.0 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $128.3 million in Q2 2022, with the low at $102.8 million in Q2 2026.
• The 5-year median for Shares Outstanding (Entity) is $107.0 million (2022), against an average of $108.6 million.
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) rose 4.73% in 2022, then declined 16.6% in 2023.
• Regeneron Pharmaceuticals' Shares Outstanding (Entity) stood at $107.1 million in 2022, then slipped by 0.37% to $106.7 million in 2023, then increased by 1.12% to $107.9 million in 2024, then dropped by 3.06% to $104.6 million in 2025, then slipped by 1.72% to $102.8 million in 2026.
• Business Quant data shows REGN's Shares Outstanding (Entity) at $102.8 million in Q2 2026, $104.0 million in Q1 2026, and $104.6 million in Q4 2025.